Agios Reports Business Highlights and Second Quarter 2021 Financial Results
July 29, 2021 07:00 ET
|
Agios Pharmaceuticals, Inc.
– Completed Regulatory Submissions for Mitapivat for the Treatment of Adults with Pyruvate Kinase (PK) Deficiency in the U.S. and EU – – Presented Data from ACTIVATE and ACTIVATE-T Phase 3 Studies...
Lucira Health to Announce Second Quarter 2021 Financial Results
July 29, 2021 07:00 ET
|
Lucira Health Inc.
EMERYVILLE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...
DMG Invests US$2M in Bosonic’s Crypto Trading Platform
July 29, 2021 07:00 ET
|
DMG Blockchain Solutions Inc.
VANCOUVER, British Columbia, July 29, 2021 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FSE: 6AX) (“DMG” or the “Company”), a vertically integrated blockchain and...
Kymera Therapeutics Appoints Karen Weisbach as Vice President, People and Culture and Jolly Bhatia as Vice President, Quality
July 29, 2021 07:00 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small...
Prospect Capital Funds $202 Million in Senior Secured Floating Rate Term Loans to Progrexion
July 29, 2021 07:00 ET
|
Prospect Capital Corporation
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”) announced today that Prospect has funded total commitments of $202 million, comprised of a $49...
Atreca Presents Initial Clinical Data from Phase 1b Trial of ATRC-101 in Select Advanced Solid Tumors
July 29, 2021 07:00 ET
|
Atreca, Inc.
Completed dose escalation portion of Phase 1b trial; ATRC-101 was well-tolerated with no dose-limiting toxicities observed Disease control associated with ATRC-101 target expression; preliminary...
FibroGen to Report Second Quarter 2021 Financial Results
July 29, 2021 07:00 ET
|
FibroGen, Inc.
SAN FRANCISCO, July 29, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2021 financial results on Monday, August 9 after the market close. FibroGen will also...
Minim Announces Pricing of $25 Million Public Offering of Common Stock
July 29, 2021 07:00 ET
|
Minim
MANCHESTER, NH, July 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Minim, Inc. (NASDAQ: MINM) (the “Company”) today announced the pricing of an underwritten public offering of 10,000,000 shares...
ConnectOne Bancorp, Inc. Reports Second Quarter 2021 Results; Declares Common Dividend
July 29, 2021 07:00 ET
|
ConnectOne Bancorp, Inc.
ENGLEWOOD CLIFFS, N.J., July 29, 2021 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net...
Passage Bio to Report Second Quarter 2021 Financial Results on August 5, 2021
July 29, 2021 07:00 ET
|
Passage Bio
PHILADELPHIA, July 29, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for rare, monogenic...
- September 26, 2024 21:32 ET Remee Wire & Cable Appoints John Orona as New Business Development Manager
- September 26, 2024 20:26 ET „LemON Tour” z Cytrynami z Syrakuz PGI przybywa na szczyt G7 ds. Rolnictwa